Hazard

Printed Circuit Board (PCB) Market size to grow by USD 19.05 billion from 2022 to 207, The rising industry automation is an emerging trend shaping the market, Technavio

Retrieved on: 
Tuesday, March 5, 2024

NOK Corp: The company offers printed circuit boards such as Single sided FPCs, Double sided FPCs, and Multilayer FPCs.

Key Points: 
  • NOK Corp: The company offers printed circuit boards such as Single sided FPCs, Double sided FPCs, and Multilayer FPCs.
  • Shenzhen Kinwong Electronic Co. Ltd: The company offers printed circuit boards such as 2, 3, 4, and 6-layer PCB.
  • Technavio's SUBSCRIPTION platform
    The Printed Circuit Board (PCB) market is experiencing a significant transformation, driven by technological advancements and the rapid proliferation of 5G, Internet of Things (IoT), and Artificial Intelligence.
  • The North American miniature circuit breaker market size is estimated to grow at a CAGR of 5.22% between 2022 and 2027.

VINSSEN Co., Ltd. Successfully Supplies Hydrogen Fuel Cell for Industry Project in Singapore

Retrieved on: 
Monday, December 11, 2023

VINSSEN Co., Ltd. (CEO Chil-Han Lee), a company specializing in the production of electric and hydrogen hybrid propulsion systems, has successfully tested and delivered a hydrogen fuel cell system for a trial project involving several key industry partners.

Key Points: 
  • VINSSEN Co., Ltd. (CEO Chil-Han Lee), a company specializing in the production of electric and hydrogen hybrid propulsion systems, has successfully tested and delivered a hydrogen fuel cell system for a trial project involving several key industry partners.
  • VINSSEN signed a contract with Shell in 2022 to supply the hydrogen fuel cell for the project.
  • The main components of the hydrogen fuel cell system delivered by VINSSEN comprise Fuel Cell Module (FCM), Integrated Converter Module (ICM), Lithium-Ion Battery (LIB), and Transformer (TR) for vessel auxiliary power generation.
  • VINSSEN plans to deploy manpower directly to the Singapore shipyard to install, integrate, and inspect the hydrogen fuel cell system.

Torex Gold Provides Quarterly Update on Media Luna Project

Retrieved on: 
Monday, October 30, 2023

TORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) provides Q3 2023 update on the development of its Media Luna Project (“Media Luna”). Unless otherwise stated, progress and milestones referenced in this press release are as of September 30, 2023.

Key Points: 
  • As of the end of September, there were twenty active headings, including eleven in Media Luna Lower and nine in Media Luna Upper.
  • As noted in the previous Media Luna update, plans for the early installation of the FeS flotation circuit and water treatment plant have been adjusted.
  • The current project plan relative to the Technical Report reflects the Company’s estimates for the completion of key project deliverables.
  • More detail on the Media Luna Project, including the feasibility study results, can be found in the Company’s most recent Technical Report dated effective March 16, 2022, filed on March 31, 2022 (“Technical Report”).

SuperKlean Announces Availability of Lockable Temperature Control Wheel Cover for Their Entire DuraMix 8000 Steam & Cold Water Hose Stations

Retrieved on: 
Tuesday, October 31, 2023

BURLINGAME, Calif., Oct. 31, 2023 /PRNewswire-PRWeb/ -- SuperKlean has begun early shipments of its 'first of many' new product announcements planned for 2024 … a Lockable Cover for Plant and Factory managers to limit access to SuperKlean's renowned DuraMix 8000 Steam & Cold Water Hose Station Mixer. Many managers had already been purchasing quantities of these small lockable units, and most recently have asked SuperKlean to provide a more elegant, customized solution, including an easy to remove lock. SuperKlean has answered their request, with this low-cost solution that fits any of the 10's of thousands of SuperKlean steam hose stations already in use, or soon to be purchased.

Key Points: 
  • Innovative Temperature Control Wheel Gives Thousands of SuperKlean Steam Hose Station Management Teams the Ability to Limit Temperature Control Access with a Low-Cost Solution!
  • BURLINGAME, Calif., Oct. 31, 2023 /PRNewswire-PRWeb/ -- SuperKlean has begun early shipments of its 'first of many' new product announcements planned for 2024 … a Lockable Cover for Plant and Factory managers to limit access to SuperKlean's renowned DuraMix 8000 Steam & Cold Water Hose Station Mixer.
  • SuperKlean has answered their request, with this low-cost solution that fits any of the 10's of thousands of SuperKlean steam hose stations already in use, or soon to be purchased.
  • Now, with SuperKlean's lockable cover, management can easily designate who has access to this important temperature control wheel.

TIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared with Chemotherapy in Global Phase 3 innovaTV 301 Trial

Retrieved on: 
Sunday, October 22, 2023

Topline results from innovaTV 301 were disclosed earlier this year following a pre-specified interim analysis conducted through an independent data monitoring committee.

Key Points: 
  • Topline results from innovaTV 301 were disclosed earlier this year following a pre-specified interim analysis conducted through an independent data monitoring committee.
  • The additional results were presented during the Presidential Symposium at the European Society of Medical Oncology (ESMO) Congress 2023.
  • In innovaTV 301, treatment-related adverse events (TRAEs) occurring in patients with TIVDAK were generally low grade and manageable with supportive care or dose modifications.
  • “We are excited to share the additional results of the innovaTV 301 trial, which demonstrated benefit in prolonging survival in patients with recurrent or metastatic cervical cancer compared with chemotherapy,” said Jan van de Winkel, Ph.D., Chief Executive Officer, Genmab.

TIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared with Chemotherapy in Global Phase 3 innovaTV 301 Trial

Retrieved on: 
Sunday, October 22, 2023

Data were presented during the Presidential Symposium at the European Society of Medical Oncology (ESMO) Congress 2023.

Key Points: 
  • Data were presented during the Presidential Symposium at the European Society of Medical Oncology (ESMO) Congress 2023.
  • The confirmed objective response rate (ORR) was also statistically significantly improved with TIVDAK (17.8%) compared with chemotherapy (5.2%); odds ratio: 4.0 [95% CI, 2.1-7.6], p
  • In innovaTV 301, treatment-related adverse events (TRAEs) occurring in patients with TIVDAK were generally low grade and manageable with supportive care and dose modifications.
  • “Recurrent or metastatic cervical cancer is a devastating disease,” said Roger Dansey, M.D., President of Research and Development and Chief Medical Officer at Seagen.

DT Research Expands Line of Military Standard Rugged Laptops with NVIDIA Graphics

Retrieved on: 
Tuesday, September 12, 2023

DT Research , the leading designer and manufacturer of purpose-built computing solutions for vertical markets, today announced the expansion of the LT300 line of fully rugged laptops designed for ultimate versatility, durability and reliability in harsh conditions.

Key Points: 
  • DT Research , the leading designer and manufacturer of purpose-built computing solutions for vertical markets, today announced the expansion of the LT300 line of fully rugged laptops designed for ultimate versatility, durability and reliability in harsh conditions.
  • The LT355 offers the option for an embedded NVIDIA RTX™ graphics card; Embedded MXM GPU with Embedded NVIDIA RTX™ A1000 or A2000 MXM.
  • Military Standard Rugged – IP65-rated for water and dust resistance; MIL-STD-810G/H for shock and vibration protection; and HERO (Hazard of Electromagnetic Radiation to Ordnance) tested.
  • The DT Research LT355 rugged laptop is immediately available from DT Research’s authorized resellers and partners, and will be featured at the DSEI 2023 show in London September 12 – 15 in stand H8-467.

U.S. FDA Approves AKEEGA™ (Niraparib and Abiraterone Acetate), the First-And-Only Dual Action Tablet for the Treatment of Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer

Retrieved on: 
Friday, August 11, 2023

HORSHAM, Pa., Aug. 11, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food & Drug Administration (FDA) has approved AKEEGA™ (niraparib and abiraterone acetate), the first-and-only dual action tablet combining a PARP inhibitor with abiraterone acetate, given with prednisone, for the treatment of adult patients with deleterious or suspected deleterious BRCA-positive mCRPC, as detected by an FDA-approved test.1

Key Points: 
  • *, Medical Oncologist at BC Cancer – Vancouver and principal investigator of the Phase 3 MAGNITUDE study.
  • "All individuals diagnosed with prostate cancer should consider genetic testing, especially those from racial and ethnic minority groups who tend to have worse cancer outcomes.
  • This is imperative to close the racial and ethnic disparities in prostate cancer health outcomes."
  • "This milestone, which marks the approval of Janssen's third prostate cancer treatment, highlights the importance of advancing precision medicine approaches and genetic testing for the treatment of patients with BRCA-positive mCRPC."

Ciltacabtagene Autoleucel (cilta-cel) Reduced Risk of Disease Progression or Death by 74% vs Standard Regimens for Adult Patients with Relapsed and Refractory Multiple Myeloma in CARTITUDE-4 Study

Retrieved on: 
Monday, June 5, 2023

Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS), including fatal and life-threatening reactions, occurred in patients following treatment with CARVYKTI®.

Key Points: 
  • Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS), including fatal and life-threatening reactions, occurred in patients following treatment with CARVYKTI®.
  • CARVYKTI® is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the CARVYKTI® REMS Program.
  • Cytokine Release Syndrome (CRS) including fatal or life-threatening reactions, occurred following treatment with CARVYKTI® in 95% (92/97) of patients receiving ciltacabtagene autoleucel.
  • Grade 3 or higher CRS (2019 ASTCT grade) occurred in 5% (5/97) of patients, with Grade 5 CRS reported in 1 patient.

Sarah Holland-Batt wins the 2023 Stella Prize with a powerful look at death and ageing

Retrieved on: 
Friday, April 28, 2023

Acclaimed poet Sarah Holland-Batt has won the 2023 Stella Prize for her powerful and elegiac collection of poetry, The Jaguar.

Key Points: 
  • Acclaimed poet Sarah Holland-Batt has won the 2023 Stella Prize for her powerful and elegiac collection of poetry, The Jaguar.
  • Poetry was excluded from the Stella Prize until 2022.

The full power of poetic language

    • The Jaguar brings the full power of poetic language to bear on experiences often pushed to the edges of public life.
    • The most stunning poems in the collection focus on the experience of ageing, illness and death – in ways that are both deeply compassionate and fierce.
    • Stella Prize chair Alice Pung says of the book:
      In The Jaguar, Sarah Holland-Batt writes about death as tenderly as we’ve ever read about birth.
    • Read more:
      First Nations poet Evelyn Araluen wins the 2022 Stella Prize with a 'wild ride' skewering colonial mythologies

The politics of bearing witness

    • Holland-Batt has spoken publicly about the neglect of aged care funding and policy in this country.
    • She made a submission to the Royal Commission into Aged Care Quality and Safety about the abuse and neglect her father suffered in aged care.
    • “Our cultural denial of death also underwrites many of our failures in aged care.” The politics of this collection reside in the act of bearing witness.
    • Read more:
      How to complain about aged care and get the result you want

Imaginative flight

    • A good example of these shifts is in the ways the jaguar of the collection’s title emerges throughout the collection.
    • I can’t make anything of it.” The jaguar of this poem also demonstrates Holland-Batt’s imaginative and linguistic power: it is at once an object of this world and a link to other understandings of the relationship between the human and the animal, especially at death.
    • With a combination of ruthlessness and tenderness, clear-eyed witness and imaginative flight, this is a poet who knows exactly what she is doing.